Financials in GBp. Standardized financial statements.
A compact view of how Abingdon Health Plc turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue? | £8.43M | £6.13M | £4.04M | £2.83M | £11.62M | £5.24M | £2.28M | £2.27M |
| Revenue Growth? | +37.4% | +51.7% | +42.7% | -75.6% | +121.9% | +129.9% | +0.4% | 0.0% |
| Cost of Revenue? | £5.30M | £2.46M | £2.64M | £8.06M | £8.22M | £1.15M | £705,383 | £924,614 |
| Gross Profit? | £3.13M | £3.68M | £1.40M | -£5.23M | £3.39M | £4.09M | £1.57M | £1.34M |
| Gross Margin? | +37.1% | +60.0% | +34.7% | -184.4% | +29.2% | +78.1% | +69.0% | +59.2% |
| Operating Expenses? | £7.15M | £5.05M | £5.25M | £6.88M | £8.91M | £7.40M | £2.97M | £6.05M |
| Operating Income? | -£4.03M | -£1.37M | -£3.85M | -£12.11M | -£5.52M | £217,000 | -£1.40M | -£4.70M |
| EBITDA? | -£3.12M | -£916,000 | -£2.81M | -£19.98M | -£6.07M | -£2.84M | -£1.10M | £8.00M |
| Income Before Tax | -£3.81M | -£1.40M | -£3.57M | -£21.68M | -£6.95M | -£3.38M | -£1.41M | £2.93M |
| Income Tax Expense | -£390,000 | -£128,000 | -£105,000 | -£331,000 | £19,000 | -£1,000 | -£154,308 | -£535,525 |
| Net Income? | -£3.42M | -£1.27M | -£3.47M | -£21.26M | -£6.97M | -£3.37M | -£1.26M | £3.47M |
| EPS? | £-0.01 | £-0.00 | £-0.01 | £-0.07 | £-0.07 | £-0.04 | £-0.01 | £0.04 |
| Diluted EPS? | £-0.01 | £-0.00 | £-0.01 | £-0.07 | £-0.07 | £-0.04 | £-0.01 | £0.04 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality